Skip to main navigation Skip to search Skip to main content

Corrigendum to “PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1” [Cancer Letters 375 (1) (2016 May 28) 190–198] (Cancer Letters (2016) 375(1) (190–198), (S0304383516301318), (10.1016/j.canlet.2016.02.053))

  • Qing Li
  • , Zhikui Liu
  • , Meng Xu
  • , Yumo Xue
  • , Bowen Yao
  • , Changwei Dou
  • , Yuli Jia
  • , Yufeng Wang
  • , Kangsheng Tu
  • , Xin Zheng
  • , Yingmin Yao
  • The First Affiliated Hospital of Xi’an Jiaotong University

Research output: Contribution to journalComment/debate

Abstract

The authors regret the error in Figure 2D and 5E in the printed version. Specifically, the Transwell images in the control group of MHCC-97H cells in Figure 2D and 5E was inadvertently placed by mistake. We have double checked the original data and found that the inadvertent errors occurred during picture compilation. The corrected Figure 2 and 5 is given here, and this correction does not change the scientific conclusions of the article. The authors all agree to this Corrigendum, and are grateful to the Editor of Cancer Letters for allowing them to have the opportunity to correct these errors. The authors would like to apologise for any inconvenience caused.[Formula

Original languageEnglish
Article number215806
JournalCancer Letters
Volume543
DOIs
StatePublished - 1 Sep 2022
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Corrigendum to “PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1” [Cancer Letters 375 (1) (2016 May 28) 190–198] (Cancer Letters (2016) 375(1) (190–198), (S0304383516301318), (10.1016/j.canlet.2016.02.053))'. Together they form a unique fingerprint.

Cite this